Global Tobacco and Nicotine Forum (GTNF) 2022

The Global Tobacco and Nicotine Forum (GTNF) will kick off its signing ceremony at the Four Seasons Hotel in Washington, D.C. on September 27th at 11:00 a.m. EST (September 28th at 11:00 p.m. Beijing time) . Since its inauguration in Rio de Janeiro, Brazil in 2008, GTNF has served as a platform for global public health experts, government officials, and professionals and investors in the tobacco and nicotine industries to exchange ideas. As a leading nicotine industry forum, numerous Chinese companies will participate in this year's event.

The conference is scheduled to take place from September 27 to September 29, lasting three days. Chinese businesses will participate in the panel discussion on September 29 under the theme of "Products: Innovation for Tomorrow." Speakers from leading Chinese companies such as Smoore Technology, Zhenwei Biology Technology, Dr. Pen Technology, Jetway Technologies, and a representative from Yunnan University's NGP Industry Research team will join hundreds of scientists, public health experts, government officials, industry leaders, and media professionals from around the world to discuss hot topics in the industry such as "low-temperature atomization", "next-generation nicotine salts", and "compatibility between e-juice and hardware" from both the enterprise and user perspectives.

Several Chinese companies were invited to participate in the forum, and many of them also provided sponsorship for the event.

These enterprises primarily include:

Companies such as Simor Technology Co., Ltd., Zhenwei Biotechnology Co., Ltd., Zhuolineng Technology Co., Ltd., Jiyi Technology Co., Ltd., Xinyikang Technology Co., Ltd., and Michael Technology Co., Ltd.

2FIRSTS will send on-site reporters for continuous coverage. For more information, click on the link below to access the GTNF forum topic.

Statement:

This article is sourced from third-party information and is provided for industry professionals for the purposes of exchange and learning.

This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The compilation of this article is only intended for communication and research within the industry.

Due to limitations in our translation abilities, the translated article may not accurately convey the same meaning as the original. Please refer to the original article for accuracy.

2FIRSTS aligns completely with the stance and positions of the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign matters.

The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.